Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-07 · accession 0001415889-25-001143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-08 | 2025-01-07 | MIRM | Peetz Christopher | CEO, Dir | S - Sale | $42.82 | -7,489 | 119.4K | -6% | -$320.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-07 | S | D | 7,489 | $42.82 | 119,359 | D | — | — |